Bresson-Dumont" found a lower diastolic and systolic blood pressure in patients with normal tension glaucoma compared with those with primary open angle glaucoma and a greater percentage of diurnal low readings in the former group. Kaiser et al " also indicated that arterial hypotension was a risk factor for glaucomatous damage. The paper by Meyer et al also shows that patients with normal tension glaucoma have larger nocturnal blood pressure drops than normal controls.
Two potential confounders of any of these studies are the use of systemic and/or ocular antihypertensives by the subjects being studied. Hayreh et al "' showed a significant association between visual field loss and nocturnal hypotension in patients taking systemic antihypertensive medications. Graham et al's paper'2 suggested that the nocturnal dip was exacerbated by systemic antihypertensives, but did not show an effect caused by topical , blockers.
The association of nocturnal blood pressure dips and visual field loss seems very plausible. Twenty four hour blood pressure monitoring has shown that the vast majority of the population have their lowest blood pressure during sleep usually between 2 and 4 am (that is, nocturnal dips in blood pressure are physiological) but, of course, not everyone has progressive field loss. What may be different about those who lose field is that they have exaggerated nocturnal dips, which in some people seem to occur naturally while in others it may be the result of antihypertensive medications.'2 It is not inconceivable that this exaggerated drop could act on an already compromised optic nerve head and reduce ocular blood flow below a critical level. If large areas of infarction occurred, the picture would be of an anterior ischaemic optic neuropathy while a number of subclinical insults may eventually produce the picture of glaucomatous field loss. Certainly the evidence that the 'dippers' are at increased risk of field loss is growing.
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